We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+12.98%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$95.4B
AUM Growth
+$9.26B
Cap. Flow
-$707M
Cap. Flow %
-0.74%
Top 10 Hldgs %
25.21%
Holding
4,380
New
32
Increased
1,513
Reduced
2,146
Closed
67

Sector Composition

Rank Sector Weight
1 Technology 27.73%
2 Financials 13%
3 Healthcare 12.09%
4 Consumer Discretionary 11.32%
5 Industrials 9.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TCRT icon
3776
Alaunos Therapeutics
TCRT
$4.86M
$451 ﹤0.01%
42
CLS icon
3777
Celestica
CLS
$36.2B
$439 ﹤0.01%
15
PPBT
3778
Purple Biotech
PPBT
$1.31M
$432 ﹤0.01%
3
KEEL
3779
Keel Infrastructure Corp
KEEL
$2.31B
$421 ﹤0.01%
145
DRRX
3780
DELISTED
DURECT Corp
DRRX
$418 ﹤0.01%
710
QNCX icon
3781
Quince Therapeutics
QNCX
$28.9M
$413 ﹤0.01%
2
DNN icon
3782
Denison Mines
DNN
$2.83B
$407 ﹤0.01%
230
SOS
3783
SOS Limited
SOS
$14.5M
$394 ﹤0.01%
6
DUO
3784
Fangdd Network Group
DUO
$22.8M
$385 ﹤0.01%
36
LIDR icon
3785
AEye
LIDR
$56.5M
$373 ﹤0.01%
163
-1
-0.6% -$5
OCFT
3786
DELISTED
OneConnect Financial Technology
OCFT
$369 ﹤0.01%
114
BPTS
3787
DELISTED
Biophytis SA American Depositary Share (0.01 Euro)
BPTS
$356 ﹤0.01%
13
PVLA
3788
Palvella Therapeutics
PVLA
$2.23B
$339 ﹤0.01%
23
BTG icon
3789
B2Gold
BTG
$5.45B
$331 ﹤0.01%
105
BB icon
3790
BlackBerry
BB
$5.15B
$318 ﹤0.01%
90
TXMD icon
3791
TherapeuticsMD
TXMD
$24.2M
$314 ﹤0.01%
140
OBE
3792
Obsidian Energy
OBE
$640M
$305 ﹤0.01%
45
ABEO icon
3793
Abeona Therapeutics
ABEO
$393M
$290 ﹤0.01%
58
OHB
3794
DELISTED
ORLEANS HOMEBUILDERS INC
OHB
$290 ﹤0.01%
2,900
MDXH icon
3795
MDxHealth
MDXH
$22.5M
$283 ﹤0.01%
72
PDS
3796
Precision Drilling
PDS
$989M
$271 ﹤0.01%
5
AGI icon
3797
Alamos Gold
AGI
$13B
$269 ﹤0.01%
20
SGML icon
3798
Sigma Lithium
SGML
$1.21B
$252 ﹤0.01%
8
UBX
3799
DELISTED
Unity Biotechnology
UBX
$248 ﹤0.01%
129
UXIN
3800
Uxin Ltd
UXIN
$222M
$245 ﹤0.01%
35

Similar funds

RhumbLine Advisers's Q4 2023 Portfolio in Review

As of Q4 2023, RhumbLine Advisers held 4,380 positions worth $95.4B, up 11% from $86.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Trading was light in Q4 2023: portfolio turnover was 2.3%. RhumbLine Advisers opened 32 new positions and exited 67, leaving the 4,380-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q4 2023 buy was CRH: 83,048 shares worth $5.74M.
  • RhumbLine Advisers added most to iShares Russell 1000 ETF in Q4 2023, an estimated $99.9M increase.
  • RhumbLine Advisers's biggest Q4 2023 reduction was Apple, cutting an estimated $72.7M.
  • RhumbLine Advisers fully exited Activision Blizzard in Q4 2023, selling an estimated $139M.
  • RhumbLine Advisers's ten largest holdings make up 25% of its $95.4B portfolio in Q4 2023.
  • RhumbLine Advisers opened 32 new positions and closed 67 in Q4 2023.
  • RhumbLine Advisers's portfolio value rose 11% quarter-over-quarter to $95.4B.

Based on RhumbLine Advisers's 13F filing for Q4 2023, filed 8 Feb 2024.